TETERBORO, N.J., Oct 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Kenneth W. Freeman,
Chairman and Chief Executive Officer, is scheduled to speak at the Salomon Smith
Barney 2002 Global Health Care Conference on Monday, October 28, 2002, at The
Plaza Hotel in New York City. The Quest Diagnostics presentation is scheduled to
begin at 10:15 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://www.veracast.com/ssb/2002/healthcare/57105198.cfm and to the public on
http://www.questdiagnostics.com . In addition, the archived webcast will be
available until Wednesday, November 27, 2002.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory services through its national network of laboratories and
patient service centers. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based medical testing, and empowers healthcare
organizations and clinicians with state-of-the-art connectivity solutions that
improve practice management. Additional company information can be found on the
Internet at: http://www.questdiagnostics.com .
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause actual results and outcomes to
be materially different. Certain of these risks and uncertainties may include,
but are not limited to, unanticipated expenditures, changing relationships with
customers, suppliers and strategic partners, conditions of the economy and other
factors described in the Quest Diagnostics Incorporated 2001 Form 10-K and
subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT:
Gary Samuels, Media, +1-201-393-5700, or Laure Park, Investors,
+1-201-393-5030, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
Copyright (C) 2002 PR Newswire. All rights reserved.